id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02459119
|
1:24:cancer,44:64:cancer,,,82:97:cancer,101:126:cancer
|
cervical cancer in-situ, treated localized basal cell carcinoma, Gleason score 6 prostate cancer or superficial bladder tumor
| 3
|
[
"cervical",
"cancer",
"in-situ",
",",
"treated",
"localized",
"basal",
"cell",
"carcinoma",
",",
"Gleason",
"score",
"6",
"prostate",
"cancer",
"or",
"superficial",
"bladder",
"tumor"
] |
[
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3
] |
NCT02547818
|
32:37:treatment,42:56:chronic_disease,58:78:chronic_disease,97:118:chronic_disease,
|
Chronic daily use of high-dose NSAID for osteoarthritis, rheumatoid arthritis, or other chronic inflammatory diseases (chronic defined as 3200 mg/day for >2 weeks)
| 3
|
[
"Chronic",
"daily",
"use",
"of",
"high-dose",
"NSAID",
"for",
"osteoarthritis",
",",
"rheumatoid",
"arthritis",
",",
"or",
"other",
"chronic",
"inflammatory",
"diseases",
"(",
"chronic",
"defined",
"as",
"3200",
"mg/day",
"for",
">",
"2",
"weeks",
")"
] |
[
0,
0,
0,
0,
0,
1,
0,
2,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02138617
|
36:41:chronic_disease
|
Serious, non-healing wound, active ulcer, or untreated bone fracture
| 3
|
[
"Serious",
",",
"non-healing",
"wound",
",",
"active",
"ulcer",
",",
"or",
"untreated",
"bone",
"fracture"
] |
[
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT00919503
|
23:43:cancer
|
Patients with a known nonmalignant disease that is not clearly defined will need to be discussed with the protocol principal investigator (PI) (Dr. Lauri Burroughs) and potentially the nonmalignant board to determine if they are eligible for HCT on this study
| 3
|
[
"Patients",
"with",
"a",
"known",
"nonmalignant",
"disease",
"that",
"is",
"not",
"clearly",
"defined",
"will",
"need",
"to",
"be",
"discussed",
"with",
"the",
"protocol",
"principal",
"investigator",
"(",
"PI",
")",
"(",
"Dr.",
"Lauri",
"Burroughs",
")",
"and",
"potentially",
"the",
"nonmalignant",
"board",
"to",
"determine",
"if",
"they",
"are",
"eligible",
"for",
"HCT",
"on",
"this",
"study"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02404402
|
20:28:chronic_disease
|
Meets criteria for mild TBI
| 3
|
[
"Meets",
"criteria",
"for",
"mild",
"TBI"
] |
[
0,
0,
0,
2,
2
] |
NCT02425566
|
14:25:chronic_disease
|
diagnosis of sleep apnea or a high score in the Berlin questionnaire for sleep apnea
| 3
|
[
"diagnosis",
"of",
"sleep",
"apnea",
"or",
"a",
"high",
"score",
"in",
"the",
"Berlin",
"questionnaire",
"for",
"sleep",
"apnea"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02143050
|
40:58:cancer
|
Patients with histologically confirmed BRAFV600E melanoma
| 3
|
[
"Patients",
"with",
"histologically",
"confirmed",
"BRAFV600E",
"melanoma"
] |
[
0,
0,
0,
0,
3,
3
] |
NCT02441062
|
74:83:chronic_disease
|
Inability to lie still for the entire imaging time (due to cough, severe arthritis, etc.)
| 3
|
[
"Inability",
"to",
"lie",
"still",
"for",
"the",
"entire",
"imaging",
"time",
"(",
"due",
"to",
"cough",
",",
"severe",
"arthritis",
",",
"etc",
".",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02574728
|
31:49:treatment
|
Currently receiving any other anti-cancer agents
| 3
|
[
"Currently",
"receiving",
"any",
"other",
"anti-cancer",
"agents"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02700451
|
1:25:chronic_disease
|
Congestive heart failure
| 3
|
[
"Congestive",
"heart",
"failure"
] |
[
2,
2,
2
] |
NCT02146924
|
1:31:cancer,80:95:cancer,,116:130:treatment,134:165:treatment,196:231:treatment
|
Minimal Residual Disease (MRD) will be defined in this protocol by presence of malignant cells at 0.01% or more by flow cytometry or polymerase chain reaction (PCR) analysis at the completion of initial remission induction therapy
| 3
|
[
"Minimal",
"Residual",
"Disease",
"(",
"MRD",
")",
"will",
"be",
"defined",
"in",
"this",
"protocol",
"by",
"presence",
"of",
"malignant",
"cells",
"at",
"0.01",
"%",
"or",
"more",
"by",
"flow",
"cytometry",
"or",
"polymerase",
"chain",
"reaction",
"(",
"PCR",
")",
"analysis",
"at",
"the",
"completion",
"of",
"initial",
"remission",
"induction",
"therapy"
] |
[
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02159703
|
1:25:chronic_disease
|
unstable angina pectoris
| 3
|
[
"unstable",
"angina",
"pectoris"
] |
[
2,
2,
2
] |
NCT01742338
|
30:34:chronic_disease,36:45:chronic_disease,50:68:chronic_disease
|
Patients with a diagnosis of COPD, emphysema, or chronic bronchitis
| 3
|
[
"Patients",
"with",
"a",
"diagnosis",
"of",
"COPD",
",",
"emphysema",
",",
"or",
"chronic",
"bronchitis"
] |
[
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02966665
|
12:26:chronic_disease
|
History of variant angina
| 3
|
[
"History",
"of",
"variant",
"angina"
] |
[
0,
0,
2,
2
] |
NCT01421810
|
,88:98:treatment,119:141:chronic_disease,,224:230:treatment,,,,,,,,
|
Screening labs within age-appropriate normal range, with the exception of a mildly low hematocrit (see below) and the hormonal abnormalities inherent in obesity which could include mildly elevated luteinizing hormone (LH), lipids, testosterone, prolactin, DHEAS, E2, glucose, and insulin; and decreased follicle-stimulating hormone (FSH) and/or sex hormone-binding globulin (SHBG)
| 3
|
[
"Screening",
"labs",
"within",
"age-appropriate",
"normal",
"range",
",",
"with",
"the",
"exception",
"of",
"a",
"mildly",
"low",
"hematocrit",
"(",
"see",
"below",
")",
"and",
"the",
"hormonal",
"abnormalities",
"inherent",
"in",
"obesity",
"which",
"could",
"include",
"mildly",
"elevated",
"luteinizing",
"hormone",
"(",
"LH",
")",
",",
"lipids",
",",
"testosterone",
",",
"prolactin",
",",
"DHEAS",
",",
"E2",
",",
"glucose",
",",
"and",
"insulin",
";",
"and",
"decreased",
"follicle-stimulating",
"hormone",
"(",
"FSH",
")",
"and/or",
"sex",
"hormone-binding",
"globulin",
"(",
"SHBG",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02531880
|
12:21:allergy_name
|
Allergy to manganese
| 3
|
[
"Allergy",
"to",
"manganese"
] |
[
0,
0,
4
] |
NCT02378428
|
15:33:treatment
|
Patients with curative treatment options
| 3
|
[
"Patients",
"with",
"curative",
"treatment",
"options"
] |
[
0,
0,
1,
1,
0
] |
NCT02304458
|
46:66:treatment
|
Patients who are currently receiving another investigational drug
| 3
|
[
"Patients",
"who",
"are",
"currently",
"receiving",
"another",
"investigational",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01562626
|
44:54:chronic_disease,62:77:treatment,68:77:treatment,83:98:treatment,100:112:treatment,122:144:treatment
|
Patients who have not fully recovered from toxicities of any prior treatment with cytotoxic drugs, radiotherapy or other anti-cancer modalities (returned to baseline status as noted before most recent treatment)
| 3
|
[
"Patients",
"who",
"have",
"not",
"fully",
"recovered",
"from",
"toxicities",
"of",
"any",
"prior",
"treatment",
"with",
"cytotoxic",
"drugs",
",",
"radiotherapy",
"or",
"other",
"anti-cancer",
"modalities",
"(",
"returned",
"to",
"baseline",
"status",
"as",
"noted",
"before",
"most",
"recent",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03121352
|
28:40:treatment,42:73:treatment,77:86:treatment,,123:134:treatment
|
Patients who have received chemotherapy, small molecule targeted therapy or radiation within the 2 weeks of first dose of study drugs
| 3
|
[
"Patients",
"who",
"have",
"received",
"chemotherapy",
",",
"small",
"molecule",
"targeted",
"therapy",
"or",
"radiation",
"within",
"the",
"2",
"weeks",
"of",
"first",
"dose",
"of",
"study",
"drugs"
] |
[
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02901314
|
67:85:chronic_disease
|
unable to carry out physical activity, including walking,due to a chronic disability or documented medical condition
| 3
|
[
"unable",
"to",
"carry",
"out",
"physical",
"activity",
",",
"including",
"walking",
",",
"due",
"to",
"a",
"chronic",
"disability",
"or",
"documented",
"medical",
"condition"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02233868
|
76:79:treatment
|
Presence of ferromagnetic objects in the body that are contraindicated for MRI of the head, fear of enclosed spaces, or other standard contraindication to MRI (self-report checklist)
| 3
|
[
"Presence",
"of",
"ferromagnetic",
"objects",
"in",
"the",
"body",
"that",
"are",
"contraindicated",
"for",
"MRI",
"of",
"the",
"head",
",",
"fear",
"of",
"enclosed",
"spaces",
",",
"or",
"other",
"standard",
"contraindication",
"to",
"MRI",
"(",
"self-report",
"checklist",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02401347
|
,36:62:treatment,71:80:treatment,84:106:cancer,149:164:treatment
|
Must have progressed on at least 1 prior chemotherapy regimen for the treatment of advanced breast cancer; there is no upper limit on the number of prior therapies
| 3
|
[
"Must",
"have",
"progressed",
"on",
"at",
"least",
"1",
"prior",
"chemotherapy",
"regimen",
"for",
"the",
"treatment",
"of",
"advanced",
"breast",
"cancer",
";",
"there",
"is",
"no",
"upper",
"limit",
"on",
"the",
"number",
"of",
"prior",
"therapies"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02369653
|
1:18:chronic_disease,,,,,,,,
|
Liver dysfunction manifested by SGTP (ALT) > 5X Upper limit of normal (ULN) and/or Aspartate aminotransferase (AST) >5 X ULN and/or direct (conjugated) bilirubin > 2X ULN
| 3
|
[
"Liver",
"dysfunction",
"manifested",
"by",
"SGTP",
"(",
"ALT",
")",
">",
"5X",
"Upper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
"and/or",
"Aspartate",
"aminotransferase",
"(",
"AST",
")",
">",
"5",
"X",
"ULN",
"and/or",
"direct",
"(",
"conjugated",
")",
"bilirubin",
">",
"2X",
"ULN"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02514070
|
78:92:chronic_disease,94:121:chronic_disease,,143:149:chronic_disease,151:159:chronic_disease
|
Subjects with any acute and life-threatening condition, such as prior sudden cardiac arrest, acute myocardial infarction (last three months), stroke, embolism
| 3
|
[
"Subjects",
"with",
"any",
"acute",
"and",
"life-threatening",
"condition",
",",
"such",
"as",
"prior",
"sudden",
"cardiac",
"arrest",
",",
"acute",
"myocardial",
"infarction",
"(",
"last",
"three",
"months",
")",
",",
"stroke",
",",
"embolism"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2
] |
NCT02744352
|
12:29:allergy_name,31:47:allergy_name,49:57:allergy_name,59:67:allergy_name,69:82:allergy_name,98:136:allergy_name
|
Allergy to local anesthetics, systemic opioids (fentanyl, morphine, hydromorphone and any of the drugs included in the standard of care
| 3
|
[
"Allergy",
"to",
"local",
"anesthetics",
",",
"systemic",
"opioids",
"(",
"fentanyl",
",",
"morphine",
",",
"hydromorphone",
"and",
"any",
"of",
"the",
"drugs",
"included",
"in",
"the",
"standard",
"of",
"care"
] |
[
0,
0,
4,
4,
0,
4,
4,
0,
4,
0,
4,
0,
4,
0,
0,
0,
0,
4,
4,
4,
4,
4,
4,
4
] |
NCT00085982
|
18:31:chronic_disease
|
Known infectious liver disease
| 3
|
[
"Known",
"infectious",
"liver",
"disease"
] |
[
0,
0,
2,
2
] |
NCT01951885
|
1:29:cancer
|
Chronic lymphocytic leukemia
| 3
|
[
"Chronic",
"lymphocytic",
"leukemia"
] |
[
3,
3,
3
] |
NCT02413047
|
1:8:chronic_disease,,
|
Crohn's patients have a Harvey Bradshaw index >5
| 3
|
[
"Crohn",
"'s",
"patients",
"have",
"a",
"Harvey",
"Bradshaw",
"index",
">",
"5"
] |
[
2,
2,
2,
2,
2,
2,
2,
2,
2,
2
] |
NCT02085941
|
1:24:chronic_disease,,
|
impaired renal function (eGFR < 60ml/min)
| 3
|
[
"impaired",
"renal",
"function",
"(",
"eGFR",
"<",
"60ml/min",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02043548
|
7:17:treatment,
|
If on prednisone, the dose must be stable for 4 weeks prior to the screening visit
| 3
|
[
"If",
"on",
"prednisone",
",",
"the",
"dose",
"must",
"be",
"stable",
"for",
"4",
"weeks",
"prior",
"to",
"the",
"screening",
"visit"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02058095
|
41:55:treatment
|
Patients taking the following selective alpha blockers and who are unable to stop for the duration of the study
| 3
|
[
"Patients",
"taking",
"the",
"following",
"selective",
"alpha",
"blockers",
"and",
"who",
"are",
"unable",
"to",
"stop",
"for",
"the",
"duration",
"of",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02911467
|
19:32:cancer
|
For patients with target lesion in prostate/prostatic bed
| 3
|
[
"For",
"patients",
"with",
"target",
"lesion",
"in",
"prostate/prostatic",
"bed"
] |
[
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT01993719
|
8:27:chronic_disease,46:70:treatment,73:94:chronic_disease,121:138:chronic_disease
|
Active systemic infections, (e.g.: requiring anti-infective treatment), coagulation disorders or any other active major medical illnesses
| 3
|
[
"Active",
"systemic",
"infections",
",",
"(",
"e.g",
".",
":",
"requiring",
"anti-infective",
"treatment",
")",
",",
"coagulation",
"disorders",
"or",
"any",
"other",
"active",
"major",
"medical",
"illnesses"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2
] |
NCT02468661
|
24:32:treatment
|
Acquired resistance to EGFR TKI (1st or 2nd génération)
| 3
|
[
"Acquired",
"resistance",
"to",
"EGFR",
"TKI",
"(",
"1st",
"or",
"2nd",
"génération",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02945800
|
10:25:chronic_disease
|
unstable angina pectoris
| 3
|
[
"unstable",
"angina",
"pectoris"
] |
[
0,
2,
2
] |
NCT02278692
|
28:37:allergy_name
|
Prior allergic reaction to vitamin K
| 3
|
[
"Prior",
"allergic",
"reaction",
"to",
"vitamin",
"K"
] |
[
0,
0,
0,
0,
4,
4
] |
NCT02564978
|
10:24:treatment
|
Need for ocular surgery during the course of the study
| 3
|
[
"Need",
"for",
"ocular",
"surgery",
"during",
"the",
"course",
"of",
"the",
"study"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02159495
|
,89:110:treatment
|
Research participant must be at least 2 weeks out from having received the last dose of investigational agent
| 3
|
[
"Research",
"participant",
"must",
"be",
"at",
"least",
"2",
"weeks",
"out",
"from",
"having",
"received",
"the",
"last",
"dose",
"of",
"investigational",
"agent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02555189
|
21:26:cancer,30:53:cancer,55:83:cancer,107:122:cancer
|
adequately treated, basal or squamous cell carcinoma, non-melanomatous skin cancer or curatively resected cervical cancer
| 3
|
[
"adequately",
"treated",
",",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
",",
"non-melanomatous",
"skin",
"cancer",
"or",
"curatively",
"resected",
"cervical",
"cancer"
] |
[
0,
0,
0,
3,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
3,
3
] |
NCT01994382
|
10:22:cancer,,
|
Previous malignancies within 2 yrs. unless relapse risk is small (< 5%)
| 3
|
[
"Previous",
"malignancies",
"within",
"2",
"yrs",
".",
"unless",
"relapse",
"risk",
"is",
"small",
"(",
"<",
"5",
"%",
")"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02508038
|
1:15:treatment
|
Haploidentical by HLA-typing
| 3
|
[
"Haploidentical",
"by",
"HLA-typing"
] |
[
1,
0,
0
] |
NCT01873131
|
37:48:cancer
|
Infant with one or more superficial hemangiomas in the preproliferative phase or very early proliferative growth phase
| 3
|
[
"Infant",
"with",
"one",
"or",
"more",
"superficial",
"hemangiomas",
"in",
"the",
"preproliferative",
"phase",
"or",
"very",
"early",
"proliferative",
"growth",
"phase"
] |
[
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03067571
|
30:64:chronic_disease,68:79:chronic_disease,,,,,245:256:chronic_disease,,
|
known to be seropositive for human immunodeficiency virus (HIV) or hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg] or antibodies to hepatitis B surface and core antigens [anti-HBs and anti-HBc, respectively]) or hepatitis C (anti-hepatitis C virus [HCV] antibody positive or HCV-ribonucleic acid [RNA] quantitation positive)
| 3
|
[
"known",
"to",
"be",
"seropositive",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"hepatitis",
"B",
"(",
"defined",
"by",
"a",
"positive",
"test",
"for",
"hepatitis",
"B",
"surface",
"antigen",
"[",
"HBsAg",
"]",
"or",
"antibodies",
"to",
"hepatitis",
"B",
"surface",
"and",
"core",
"antigens",
"[",
"anti-HBs",
"and",
"anti-HBc",
",",
"respectively",
"]",
")",
"or",
"hepatitis",
"C",
"(",
"anti-hepatitis",
"C",
"virus",
"[",
"HCV",
"]",
"antibody",
"positive",
"or",
"HCV-ribonucleic",
"acid",
"[",
"RNA",
"]",
"quantitation",
"positive",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02907983
|
1:23:chronic_disease
|
traumatic brain injury
| 3
|
[
"traumatic",
"brain",
"injury"
] |
[
2,
2,
2
] |
NCT01481974
|
31:45:treatment
|
Individuals who are receiving methylene blue
| 3
|
[
"Individuals",
"who",
"are",
"receiving",
"methylene",
"blue"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02510417
|
,,62:98:treatment
|
Negative pregnancy test (if female of childbearing potential after reduced intensity conditioning)
| 3
|
[
"Negative",
"pregnancy",
"test",
"(",
"if",
"female",
"of",
"childbearing",
"potential",
"after",
"reduced",
"intensity",
"conditioning",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0
] |
NCT02406599
|
1:42:treatment
|
Previous radiation in the operated breast
| 3
|
[
"Previous",
"radiation",
"in",
"the",
"operated",
"breast"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT01639508
|
10:25:chronic_disease
|
unstable angina pectoris
| 3
|
[
"unstable",
"angina",
"pectoris"
] |
[
0,
2,
2
] |
NCT01799538
|
7:24:chronic_disease,32:42:cancer,44:65:chronic_disease,69:84:chronic_disease,86:101:chronic_disease,103:122:chronic_disease,124:139:chronic_disease
|
Major systemic diseases (i.e., malignancy; myocardial infarction or unstable angina; type 1 diabetes, severe hypertension; liver cirrhosis)
| 3
|
[
"Major",
"systemic",
"diseases",
"(",
"i.e.",
",",
"malignancy",
";",
"myocardial",
"infarction",
"or",
"unstable",
"angina",
";",
"type",
"1",
"diabetes",
",",
"severe",
"hypertension",
";",
"liver",
"cirrhosis",
")"
] |
[
0,
2,
2,
0,
0,
0,
3,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0
] |
NCT02008656
|
39:42:treatment
|
Patients who are unable to undergo an MRI
| 3
|
[
"Patients",
"who",
"are",
"unable",
"to",
"undergo",
"an",
"MRI"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03085485
|
24:48:chronic_disease,,,69:82:chronic_disease,84:107:chronic_disease
|
Clinically significant congestive heart failure (known LVEF <= 45%, cor pulmonale, diastolic heart failure, etc
| 3
|
[
"Clinically",
"significant",
"congestive",
"heart",
"failure",
"(",
"known",
"LVEF",
"<",
"=",
"45",
"%",
",",
"cor",
"pulmonale",
",",
"diastolic",
"heart",
"failure",
",",
"etc"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0
] |
NCT01937884
|
10:23:treatment
|
previous bowel surgery
| 3
|
[
"previous",
"bowel",
"surgery"
] |
[
0,
1,
1
] |
NCT01734512
|
20:42:treatment
|
Patients receiving concomitant medication that may interfere with study outcome
| 3
|
[
"Patients",
"receiving",
"concomitant",
"medication",
"that",
"may",
"interfere",
"with",
"study",
"outcome"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02213575
|
1:21:treatment,
|
antibiotic treatment within 2 months of study enrollment
| 3
|
[
"antibiotic",
"treatment",
"within",
"2",
"months",
"of",
"study",
"enrollment"
] |
[
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02132598
|
32:43:chronic_disease
|
clinically-significant cardiac arrhythmias
| 3
|
[
"clinically-significant",
"cardiac",
"arrhythmias"
] |
[
0,
0,
2
] |
NCT02562430
|
40:49:treatment
|
Color-blindness for blue or green (see fMRI task)
| 3
|
[
"Color-blindness",
"for",
"blue",
"or",
"green",
"(",
"see",
"fMRI",
"task",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02181478
|
1:35:cancer
|
Acute lymphoblastic leukemia (ALL)
| 3
|
[
"Acute",
"lymphoblastic",
"leukemia",
"(",
"ALL",
")"
] |
[
3,
3,
3,
3,
0,
0
] |
NCT01804634
|
10:35:treatment
|
Positive leukocytotoxic crossmatch
| 3
|
[
"Positive",
"leukocytotoxic",
"crossmatch"
] |
[
0,
1,
1
] |
NCT02574455
|
25:37:treatment,56:59:treatment,61:69:treatment,71:83:treatment,85:96:treatment,101:112:treatment
|
Eligible for one of the chemotherapy options listed as TPC (Eribulin, capecitabine, gemcitabine, or vinorelbine) as per investigator assessment
| 3
|
[
"Eligible",
"for",
"one",
"of",
"the",
"chemotherapy",
"options",
"listed",
"as",
"TPC",
"(",
"Eribulin",
",",
"capecitabine",
",",
"gemcitabine",
",",
"or",
"vinorelbine",
")",
"as",
"per",
"investigator",
"assessment"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT03042689
|
1:20:chronic_disease,31:54:treatment,66:79:treatment,83:90:treatment
|
Cardiac arrhythmias requiring anti-arrhythmic therapy other than beta blockers or digoxin
| 3
|
[
"Cardiac",
"arrhythmias",
"requiring",
"anti-arrhythmic",
"therapy",
"other",
"than",
"beta",
"blockers",
"or",
"digoxin"
] |
[
2,
2,
0,
1,
1,
0,
0,
1,
1,
0,
1
] |
NCT02272998
|
30:61:chronic_disease
|
Patients with any history of arterial thromboembolic disease
| 3
|
[
"Patients",
"with",
"any",
"history",
"of",
"arterial",
"thromboembolic",
"disease"
] |
[
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02544373
|
,14:25:chronic_disease,
|
Score of >=2 sleep apnea risk factors on the STOP-Bang sleep apnea screening questionnaire
| 3
|
[
"Score",
"of",
">",
"=2",
"sleep",
"apnea",
"risk",
"factors",
"on",
"the",
"STOP-Bang",
"sleep",
"apnea",
"screening",
"questionnaire"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01776190
|
,51:66:chronic_disease
|
You must be 18 years or older with a diagnosis of cutaneous lupus
| 3
|
[
"You",
"must",
"be",
"18",
"years",
"or",
"older",
"with",
"a",
"diagnosis",
"of",
"cutaneous",
"lupus"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01626079
|
1:24:chronic_disease,35:42:treatment,46:72:treatment
|
Tricuspid valve disease requiring surgery or transcatheter intervention
| 3
|
[
"Tricuspid",
"valve",
"disease",
"requiring",
"surgery",
"or",
"transcatheter",
"intervention"
] |
[
2,
2,
2,
0,
1,
0,
1,
1
] |
NCT02772237
|
84:94:treatment
|
The student-athlete has already participated in the study during which he/she took Riboflavin
| 3
|
[
"The",
"student-athlete",
"has",
"already",
"participated",
"in",
"the",
"study",
"during",
"which",
"he/she",
"took",
"Riboflavin"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01815359
|
11:26:treatment,
|
Use of an oral medication, lacking a suitable non-oral substitute, that if held for up to ten days, would be felt an unacceptable risk by the investigator
| 3
|
[
"Use",
"of",
"an",
"oral",
"medication",
",",
"lacking",
"a",
"suitable",
"non-oral",
"substitute",
",",
"that",
"if",
"held",
"for",
"up",
"to",
"ten",
"days",
",",
"would",
"be",
"felt",
"an",
"unacceptable",
"risk",
"by",
"the",
"investigator"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02114229
|
42:63:chronic_disease,88:96:chronic_disease,98:111:chronic_disease,113:138:treatment,142:159:treatment,250:266:treatment,382:405:treatment
|
Other severe acute or chronic medical or psychiatric condition, including uncontrolled diabetes, malabsorption, resection of the pancreas or upper small-bowel, or requirement for pancreatic enzymes, any condition that would modify the absorption of oral medications in the small bowel or any laboratory abnormality that may increase the risk associated with study participation or investigational product administration or that may interfere with the interpretation of study results and, in the judgment of the investigator, would make the patient inappropriate for enrollment in this study
| 3
|
[
"Other",
"severe",
"acute",
"or",
"chronic",
"medical",
"or",
"psychiatric",
"condition",
",",
"including",
"uncontrolled",
"diabetes",
",",
"malabsorption",
",",
"resection",
"of",
"the",
"pancreas",
"or",
"upper",
"small-bowel",
",",
"or",
"requirement",
"for",
"pancreatic",
"enzymes",
",",
"any",
"condition",
"that",
"would",
"modify",
"the",
"absorption",
"of",
"oral",
"medications",
"in",
"the",
"small",
"bowel",
"or",
"any",
"laboratory",
"abnormality",
"that",
"may",
"increase",
"the",
"risk",
"associated",
"with",
"study",
"participation",
"or",
"investigational",
"product",
"administration",
"or",
"that",
"may",
"interfere",
"with",
"the",
"interpretation",
"of",
"study",
"results",
"and",
",",
"in",
"the",
"judgment",
"of",
"the",
"investigator",
",",
"would",
"make",
"the",
"patient",
"inappropriate",
"for",
"enrollment",
"in",
"this",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
1,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03059355
|
1:14:chronic_disease
|
Liver disease
| 3
|
[
"Liver",
"disease"
] |
[
2,
2
] |
NCT02759575
|
22:75:cancer
|
previously untreated stage III or IV squamous cell carcinoma of the larynx
| 3
|
[
"previously",
"untreated",
"stage",
"III",
"or",
"IV",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"larynx"
] |
[
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT02731326
|
12:34:chronic_disease
|
Documented permanent (chronic) AF
| 3
|
[
"Documented",
"permanent",
"(",
"chronic",
")",
"AF"
] |
[
0,
2,
2,
2,
0,
0
] |
NCT02513797
|
16:34:treatment,67:86:treatment,91:104:cancer
|
Any history of thoracic radiation with the exception of localized radiation treatment for breast cancer
| 3
|
[
"Any",
"history",
"of",
"thoracic",
"radiation",
"with",
"the",
"exception",
"of",
"localized",
"radiation",
"treatment",
"for",
"breast",
"cancer"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT01864265
|
13:32:chronic_disease
|
Evidence of active tuberculosis
| 3
|
[
"Evidence",
"of",
"active",
"tuberculosis"
] |
[
0,
0,
2,
2
] |
NCT02369900
|
19:41:chronic_disease
|
Known significant valvular heart disease
| 3
|
[
"Known",
"significant",
"valvular",
"heart",
"disease"
] |
[
0,
0,
2,
2,
2
] |
NCT02466971
|
,,,88:96:cancer,98:112:cancer,117:162:cancer,,208:245:cancer,262:289:treatment
|
Patient has a new, unrated histologic diagnosis of stage IB2 (> 5 cm), II, IIIB or IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix or stage II-IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the vagina not amenable to curative surgical resection alone
| 3
|
[
"Patient",
"has",
"a",
"new",
",",
"unrated",
"histologic",
"diagnosis",
"of",
"stage",
"IB2",
"(",
">",
"5",
"cm",
")",
",",
"II",
",",
"IIIB",
"or",
"IVA",
"squamous",
",",
"adenocarcinoma",
",",
"or",
"adenosquamous",
"carcinoma",
"of",
"the",
"uterine",
"cervix",
"or",
"stage",
"II-IVA",
"squamous",
",",
"adenocarcinoma",
",",
"or",
"adenosquamous",
"carcinoma",
"of",
"the",
"vagina",
"not",
"amenable",
"to",
"curative",
"surgical",
"resection",
"alone"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT03006770
|
1:18:chronic_disease
|
Hepatitis C virus
| 3
|
[
"Hepatitis",
"C",
"virus"
] |
[
2,
2,
2
] |
NCT03152058
|
1:4:chronic_disease,,
|
SLE patients requiring prednisone >10 mg/day
| 3
|
[
"SLE",
"patients",
"requiring",
"prednisone",
">",
"10",
"mg/day"
] |
[
2,
0,
0,
0,
0,
0,
0
] |
NCT02554786
|
23:58:treatment,60:64:treatment,,83:86:treatment,111:114:treatment,115:119:treatment,,,136:140:treatment,,
|
Withholding period of bronchodilators prior to spirometry: SABA for ≥ 6 hours and FDC or free combinations of ICS/LABA for ≥ 48 hours, SAMA for ≥ 8 hours, xanthines >=07 days
| 3
|
[
"Withholding",
"period",
"of",
"bronchodilators",
"prior",
"to",
"spirometry",
":",
"SABA",
"for",
"≥",
"6",
"hours",
"and",
"FDC",
"or",
"free",
"combinations",
"of",
"ICS/LABA",
"for",
"≥",
"48",
"hours",
",",
"SAMA",
"for",
"≥",
"8",
"hours",
",",
"xanthines",
">",
"=07",
"days"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01582191
|
32:64:allergy_name
|
History of hypersensitivity to any component of the formulation
| 3
|
[
"History",
"of",
"hypersensitivity",
"to",
"any",
"component",
"of",
"the",
"formulation"
] |
[
0,
0,
0,
0,
4,
4,
4,
4,
4
] |
NCT02048722
|
1:25:chronic_disease
|
Congestive heart failure - New York Heart Association > class II
| 3
|
[
"Congestive",
"heart",
"failure",
"-",
"New",
"York",
"Heart",
"Association",
">",
"class",
"II"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02250664
|
29:38:treatment,51:57:treatment,106:115:treatment,119:132:treatment
|
Not currently enrolled in a treatment program for opioid dependence and/or not currently stable on their methadone or buprenorphine dose
| 3
|
[
"Not",
"currently",
"enrolled",
"in",
"a",
"treatment",
"program",
"for",
"opioid",
"dependence",
"and/or",
"not",
"currently",
"stable",
"on",
"their",
"methadone",
"or",
"buprenorphine",
"dose"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02332291
|
12:34:chronic_disease,,
|
History of developmental disorder or IQ score < 70
| 3
|
[
"History",
"of",
"developmental",
"disorder",
"or",
"IQ",
"score",
"<",
"70"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02429830
|
33:41:allergy_name,43:58:allergy_name,60:66:allergy_name,71:88:allergy_name
|
Suspected or known allergies to titanium, stainless steel, nickel, or ferrous materials
| 3
|
[
"Suspected",
"or",
"known",
"allergies",
"to",
"titanium",
",",
"stainless",
"steel",
",",
"nickel",
",",
"or",
"ferrous",
"materials"
] |
[
0,
0,
0,
0,
0,
4,
0,
4,
4,
0,
4,
0,
0,
4,
4
] |
NCT02507011
|
13:30:chronic_disease,,
|
Significant sinus tachycardia (resting heart rate > 110 bpm)
| 3
|
[
"Significant",
"sinus",
"tachycardia",
"(",
"resting",
"heart",
"rate",
">",
"110",
"bpm",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02796209
|
1:18:chronic_disease
|
mental conditions rendering the subject unable to understand the nature, scope, and possible consequences of the study
| 3
|
[
"mental",
"conditions",
"rendering",
"the",
"subject",
"unable",
"to",
"understand",
"the",
"nature",
",",
"scope",
",",
"and",
"possible",
"consequences",
"of",
"the",
"study"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00357565
|
11:14:chronic_disease
|
high risk CR1
| 3
|
[
"high",
"risk",
"CR1"
] |
[
0,
0,
2
] |
NCT02358850
|
1:19:treatment,21:57:treatment,59:115:treatment
|
Surgical procedure: Tonsillectomy with monopolar cautery, hemostasis with monopolar cautery and/or suction cautery
| 3
|
[
"Surgical",
"procedure",
":",
"Tonsillectomy",
"with",
"monopolar",
"cautery",
",",
"hemostasis",
"with",
"monopolar",
"cautery",
"and/or",
"suction",
"cautery"
] |
[
1,
1,
0,
1,
1,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1
] |
NCT02101736
|
12:28:treatment
|
History of organ transplant
| 3
|
[
"History",
"of",
"organ",
"transplant"
] |
[
0,
0,
1,
1
] |
NCT02266719
|
1:8:chronic_disease,12:29:chronic_disease,46:57:chronic_disease
|
Leaking or ruptured aneurysm associated with hypotension
| 3
|
[
"Leaking",
"or",
"ruptured",
"aneurysm",
"associated",
"with",
"hypotension"
] |
[
2,
0,
2,
2,
0,
0,
2
] |
NCT02530073
|
1:21:chronic_disease,,
|
Diaphragmatic hernia: right-sided or bilateral, major associated anomalies, isolated left-sided with the O/E LHR ≥ 25%
| 3
|
[
"Diaphragmatic",
"hernia",
":",
"right-sided",
"or",
"bilateral",
",",
"major",
"associated",
"anomalies",
",",
"isolated",
"left-sided",
"with",
"the",
"O/E",
"LHR",
"≥",
"25",
"%"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02764801
|
25:39:chronic_disease
|
with known or suspected cardiac shunts
| 3
|
[
"with",
"known",
"or",
"suspected",
"cardiac",
"shunts"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT01620216
|
20:25:chronic_disease
|
Non-healing wound, ulcer, or bone fracture
| 3
|
[
"Non-healing",
"wound",
",",
"ulcer",
",",
"or",
"bone",
"fracture"
] |
[
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02905188
|
,,61:71:treatment
|
Systemic steroid treatment (greater than or equal to 0.5 mg prednisone equivalent/kg/day)
| 3
|
[
"Systemic",
"steroid",
"treatment",
"(",
"greater",
"than",
"or",
"equal",
"to",
"0.5",
"mg",
"prednisone",
"equivalent/kg/day",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02487082
|
7:22:chronic_disease
|
Other serious illness
| 3
|
[
"Other",
"serious",
"illness"
] |
[
0,
2,
2
] |
NCT02555280
|
8:18:cancer,52:71:cancer,80:103:cancer,
|
Active malignancy: a patient with a history of any invasive malignancy (except nonmelanoma skin cancer), unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least five years
| 3
|
[
"Active",
"malignancy",
":",
"a",
"patient",
"with",
"a",
"history",
"of",
"any",
"invasive",
"malignancy",
"(",
"except",
"nonmelanoma",
"skin",
"cancer",
")",
",",
"unless",
"he/she",
"has",
"been",
"treated",
"with",
"curative",
"intent",
"and",
"there",
"has",
"been",
"no",
"clinical",
"signs",
"or",
"symptoms",
"of",
"the",
"malignancy",
"for",
"at",
"least",
"five",
"years"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525692
|
72:100:treatment,104:136:treatment,235:247:cancer,262:268:treatment
|
Unequivocal evidence of progressive disease on contrast-enhanced brain computerized tomography (CT) or magnetic resonance imaging (MRI) as defined by Response Assessment in Neuro-Oncology Criteria (RANO), or have documented recurrent glioblastoma on diagnostic biopsy
| 3
|
[
"Unequivocal",
"evidence",
"of",
"progressive",
"disease",
"on",
"contrast-enhanced",
"brain",
"computerized",
"tomography",
"(",
"CT",
")",
"or",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
"as",
"defined",
"by",
"Response",
"Assessment",
"in",
"Neuro-Oncology",
"Criteria",
"(",
"RANO",
")",
",",
"or",
"have",
"documented",
"recurrent",
"glioblastoma",
"on",
"diagnostic",
"biopsy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
1
] |
NCT02416206
|
36:66:chronic_disease
|
Patients who have any debilitating medical or psychiatric illness which would preclude their giving informed consent or their receiving optimal treatment and follow-up
| 3
|
[
"Patients",
"who",
"have",
"any",
"debilitating",
"medical",
"or",
"psychiatric",
"illness",
"which",
"would",
"preclude",
"their",
"giving",
"informed",
"consent",
"or",
"their",
"receiving",
"optimal",
"treatment",
"and",
"follow-up"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02264236
|
21:33:cancer,
|
Subjects with other malignancies are eligible if they have been continuously disease free for ≥ 5 years prior to the time of registration
| 3
|
[
"Subjects",
"with",
"other",
"malignancies",
"are",
"eligible",
"if",
"they",
"have",
"been",
"continuously",
"disease",
"free",
"for",
"≥",
"5",
"years",
"prior",
"to",
"the",
"time",
"of",
"registration"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02201992
|
10:40:treatment,
|
Baseline chest computed tomography (CT) with or without contrast must be performed within 6 months (180 days) prior to randomization to ensure no evidence of disease
| 3
|
[
"Baseline",
"chest",
"computed",
"tomography",
"(",
"CT",
")",
"with",
"or",
"without",
"contrast",
"must",
"be",
"performed",
"within",
"6",
"months",
"(",
"180",
"days",
")",
"prior",
"to",
"randomization",
"to",
"ensure",
"no",
"evidence",
"of",
"disease"
] |
[
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01716806
|
1:13:treatment,15:27:treatment,29:38:treatment,68:81:treatment,,127:137:treatment
|
Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed 4 weeks prior to first dose of study drug
| 3
|
[
"Chemotherapy",
",",
"radiotherapy",
",",
"biologics",
",",
"and/or",
"other",
"treatment",
"with",
"immunotherapy",
"not",
"completed",
"4",
"weeks",
"prior",
"to",
"first",
"dose",
"of",
"study",
"drug"
] |
[
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.